Minerva Surgical
Pre-clinicalMinerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $150M
About
Minerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
Medical Devices
Funding History
3Total raised:$150M
IPO$75MSep 23, 2021
Series B$45MMar 15, 2017
Series A$30MJun 15, 2015